AAAAAA
Results:
1-21
|
Results: 21
Authors:
PADOVAN CS
YOUSRY TA
SCHLEUNING M
HOLLER E
KOLB HJ
STRAUBE A
Citation: Cs. Padovan et al., NEUROLOGICAL AND NEURORADIOLOGICAL FINDINGS IN LONG-TERM SURVIVORS OFALLOGENEIC BONE-MARROW TRANSPLANTATION, Annals of neurology, 43(5), 1998, pp. 627-633
Authors:
SCHLEUNING M
MITTERMULLER J
KOLB HJ
Citation: M. Schleuning et al., MONITORING OF CHRONIC MYELOGENOUS LEUKEMIA PATIENTS BY SEMIQUANTITATIVE BCR-ABL PROTEIN-DETECTION IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS, Experimental hematology, 26(8), 1998, pp. 414-414
Authors:
KOLB HJ
MENZEL H
HOLLER E
SCHLEUNING M
LEDDEROSE G
WEISSINGER E
MITTERMULLER J
Citation: Hj. Kolb et al., ADOPTIVE IMMUNOTHERAPY FOR LEUKEMIA, Bone marrow transplantation, 22, 1998, pp. 8-8
Authors:
KAPPICHT S
LEDDEROSE G
MENZEL H
MUTH A
KOLB HJ
SCHLEUNING M
Citation: S. Kappicht et al., DMSO-INDUCED IN-VITRO AND IN-VIVO COMPLEMENT ACTIVATION AS A POSSIBLECAUSE OF ADVERSE REACTIONS OBSERVED DURING REINFUSION OF FROZEN PERIPHERAL-BLOOD STEM-CELLS AND BONE-MARROW, Bone marrow transplantation, 21, 1998, pp. 47-47
Authors:
KOLB HJ
HOLLER E
LEDDEROSE G
SALAT C
MUTH A
GUNTHER C
SCHLEUNING M
MEMPEL W
Citation: Hj. Kolb et al., ADOPTIVE IMMUNOTHERAPY OF RELAPSE OF ACUTE-LEUKEMIA AND ADVANCED PHASE CML WITH BLOOD STEM-CELLS AND GM-CSF, Bone marrow transplantation, 21, 1998, pp. 253-253
Authors:
KAPPICHT S
LEDDEROSE G
MENZEL H
MUTH A
KOLB HJ
SCHLEUNING M
Citation: S. Kappicht et al., IN-VITRO AND IN-VIVO COMPLEMENT ACTIVATION BY DMSO AS A POSSIBLE CAUSE OF ADVERSE REACTIONS OBSERVED DURING REINFUSION OF FROZEN AUTOLOGOUSPERIPHERAL STEM-CELLS, Experimental hematology, 25(8), 1997, pp. 304-304
Authors:
SCHLEUNING M
BRUMME V
WILMANNS W
KOLB HJ
Citation: M. Schleuning et al., THERAPEUTIC STRATEGY BASED ON SEMIQUANTITATIVE BCR-ABL PCR FOR MOLECULAR OR CYTOGENETIC RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA (CML), Experimental hematology, 25(8), 1997, pp. 622-622
Authors:
SCHLEUNING M
JAGER G
HOLLER E
HILL W
THOMSSEN C
DENZLINGER C
LORENZ T
MUTH A
KOLB HJ
Citation: M. Schleuning et al., THE INCIDENCE OF HUMAN PARVOVIRUS B19 INFECTION IN BONE-MARROW TRANSPLANTATION PATIENTS AND ITS IMPACT ON TRANSPLANT-RELATED MORBIDITY AND MORTALITY, Experimental hematology, 24(9), 1996, pp. 651-651
Authors:
HILL W
HOLLER E
SCHLEUNING M
SCHMID M
MUTH A
HILL C
KOLB HJ
WILMANNS W
Citation: W. Hill et al., AVASCULAR NECROSIS OF BONE AFTER BONE-MARROW TRANSPLANTATION - INCIDENCE, CLINICAL FINDINGS AND RISK-FACTORS, Blood, 88(10), 1996, pp. 1039-1039
Authors:
SALAT C
HOLLER E
SCHLEUNING M
EISELE B
REINHARDT B
KOLB H
PIHUSCH R
DOMRATH R
HILLER E
Citation: C. Salat et al., LEVELS OF THE TERMINAL COMPLEMENT COMPLEX, C3A-DESARG AND C1-INHIBITOR IN ADULT PATIENTS WITH CAPILLARY LEAK SYNDROME FOLLOWING BONE-MARROWTRANSPLANTATION, Annals of hematology, 71(6), 1995, pp. 271-274
Authors:
BOCK M
SCHLEUNING M
HEIM MU
MEMPEL W
Citation: M. Bock et al., CRYOPRESERVATION OF HUMAN PLATELETS WITH DIMETHYL-SULFOXIDE - CHANGESIN BIOCHEMISTRY AND CELL-FUNCTION, Transfusion, 35(11), 1995, pp. 921-924
Authors:
HOLLER E
KOLB HJ
MITTERMULLER J
KAUL M
LEDDEROSE G
DUELL T
SEEBER B
SCHLEUNING M
HINTERMEIERKNABE R
ERTL B
KEMPENI J
WILMANNS W
Citation: E. Holler et al., MODULATION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION BY TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) RELEASE IN THE COURSE OF PRETRANSPLANT CONDITIONING - ROLE OF CONDITIONING REGIMENS AND PROPHYLACTIC APPLICATION OF A MONOCLONAL-ANTIBODY NEUTRALIZING HUMAN TNF-ALPHA (MAK 195F), Blood, 86(3), 1995, pp. 890-899
Authors:
KOLB HJ
HOLLER E
KNABE H
LEDDEROSE G
MITTERMUELLER J
SCHLEUNING M
MAYER F
GOLDMANN SF
FISCHER M
LORENZ T
HILL W
SCHUH R
Citation: Hj. Kolb et al., CONDITIONING TREATMENT WITH ANTITHYMOCYTE GLOBULIN (ATG) MODIFIES GRAFT-VS-HOST DISEASE IN RECIPIENTS OF MARROW FROM UNRELATED DONORS, Blood, 86(10), 1995, pp. 3798-3798
Authors:
SCHLEUNING M
THOMSSEN C
KOLB HJ
SAUER HJ
WILMANNS W
Citation: M. Schleuning et al., TREATMENT OF REFRACTORY SEVERE APLASTIC-ANEMIA WITH GRANULOCYTE-COLONY-STIMULATING FACTOR AND INTERLEUKIN-3, American journal of hematology, 46(3), 1994, pp. 250-251
Authors:
SCHLEUNING M
BOCK M
MEMPEL W
Citation: M. Schleuning et al., COMPLEMENT ACTIVATION DURING STORAGE OF SINGLE-DONOR PLATELET CONCENTRATES, Vox sanguinis, 67(2), 1994, pp. 144-148
Authors:
SCHLEUNING M
BRUMME V
WILMANNS W
Citation: M. Schleuning et al., INHIBITION OF CYCLOSPORINE A FK506 RESISTANT, LYMPHOKINE-INDUCED T-CELL ACTIVATION BY PHENOTHIAZINE-DERIVATIVES/, Naunyn-Schmiedeberg's archives of pharmacology, 350(1), 1994, pp. 100-103
Authors:
GERL A
CLEMM C
SCHLEUNING M
WILMANNS W
Citation: A. Gerl et al., FATAL CEREBROVASCULAR ACCIDENT ASSOCIATED WITH CHEMOTHERAPY FOR TESTICULAR CANCER, European journal of cancer, 29A(8), 1993, pp. 1220-1221
Authors:
SCHLEUNING M
THOMSSEN C
SAUER H
KOLB HJ
WILMANNS W
Citation: M. Schleuning et al., TREATMENT OF REFRACTORY SEVERE APLASTIC-ANEMIA WITH CYTOKINES, Experimental hematology, 21(8), 1993, pp. 1093-1093
Authors:
SCHLEUNING M
BRUMME V
WILMANNS W
Citation: M. Schleuning et al., GROWTH-INHIBITION OF HUMAN LEUKEMIC-CELL LINES BY THE PHENOTHIAZINE DERIVATIVE FLUPHENAZINE, Anticancer research, 13(3), 1993, pp. 599-602
Authors:
BOCK M
GLASER A
PFOSSER A
SCHLEUNING M
HEIM MU
MEMPEL W
Citation: M. Bock et al., STORAGE OF SINGLE-DONOR PLATELET CONCENTRATES - METABOLIC AND FUNCTIONAL-CHANGES, Transfusion, 33(4), 1993, pp. 311-315
Authors:
SCHLEUNING M
THOMSSEN C
KOLB HJ
SAUER H
WILMANNS W
Citation: M. Schleuning et al., 61-YEAR-OLD PATIENT WITH HEMORRHAGIC DIAT HESIS AND REDUCED ACTIVITY - SEVERE APLASTIC-ANEMIA, Der Internist, 34(12), 1993, pp. 1141-1145
Risultati:
1-21
|